Moderna, Inc. Stock Performance
as on October 29, 2025 at 1:29 am IST
Day's Low
Day's High
$25.2$26.9
0.63%
Downside
6.07%
Upside
52 Week's Low
52 Week's High
$23.15$57.698.71%
Downside
127.48%
Upside
Moderna, Inc. share price movements today
- Previous Close
- $26.66
- Open
- $26.62
- Volume
- 8.2M
- Day's Low - High
- $25.2 - $26.9
- 52 Week Low - High
- $23.15 - $57.69
Moderna, Inc. Historical Returns
- 1 Month Return
- + 8.86 %
- 3 Month Return
- -21.38 %
- 1 Year Return
- -51.35 %
- 3 Year Return
- -82.34 %
- 5 Year Return
- -59.45 %
Moderna, Inc. Stock Fundamentals & Key Indicators
Check Moderna, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.4B
EPS (TTM)
-9.7671
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.85%
PE Ratio (TTM)
-5.08
Industry PE ratio
19.200384615384614
PEG Ratio
0EBITDA
-3.1B
Revenue (TTM)
3.1B
Profit Margin
-94.31%
Return On Equity TTM
-27.50%
Moderna, Inc. Stock Valuation
Track how Moderna, Inc. P/E has moved over time to understand its valuation trends.
Moderna, Inc. in the last 5 years
Lowest (-52.15x)
December 31, 2020
Today (-5.08x)
October 28, 2025
Industry (19.20x)
October 28, 2025
Highest (115.93x)
March 31, 2021
Today’s Price to Earnings Ratio: -5.08x
Moderna, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Moderna, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.4B | -59.45% | -5.08 | -94.31% | |
| BUY | $60.7B | 283.23% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 101.68% | 29.95 | 31.86% | |
| BUY | $61.3B | 3.22% | 14.55 | 31.37% |
Stock Returns calculator for Moderna, Inc. Stock including INR - Dollar returns
The Moderna, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moderna, Inc. investment value today
Current value as on today
₹51,409
Returns
Returns from Moderna, Inc. Stock
Dollar Returns*
₹5,132 (+5.13%)
Analyst Recommendation on Moderna, Inc. Stock
Based on 31 analysts
54.84%
Buy
35.48%
Hold
9.68%
Sell
Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna, Inc.. Average target price of $40.3
Moderna, Inc. Share Price Target
Get share price movements and forecasts by analysts on Moderna, Inc..
What analysts predicted
37.07%UPSIDE
Target Price
$40.3
Current Price
$25.36
Analyzed by
31 Analysts
Target
$40.30
Moderna, Inc. target price $40.3, a slight upside of 37.07% compared to current price of $25.36. According to 31 analysts rating.
Moderna, Inc. Stock’s Investor Sentiment and Interest
Investment in Moderna, Inc. Shares on INDmoney has dropped by -31.00% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Moderna, Inc. Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:26% versus previous 30 day period
Moderna, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Moderna, Inc. Annual Profit & Loss
All numbers in Millions USD
Moderna, Inc. Quarterly Cash Flow
All numbers in Millions USD
Moderna, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Moderna, Inc. Stock
Check out the Mutual Funds with significant holdings in Moderna, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.01561% | 2747 |
Global Institutional Holdings in Moderna, Inc.
Moderna, Inc. News & Key Events
Today's Timeline - 23 October
Thu, 02:53 PM
-Moderna expected to report significant losses in upcoming earnings, with a consensus Hold rating.
Thu, 02:58 PM
-Moderna shares fall 3.5% after CMV vaccine trial misses target; analysts maintain mixed ratings.
Thu, 07:27 PM
-Oddo BHF lowers Moderna's target price from $51 to $47 after CMV program discontinuation.
Today's Timeline - 23 October
Thu, 07:56 PM
-Moderna's CMV vaccine trial fails, leading to a 4.15% drop in premarket stock price.
Thu, 09:03 PM
-New options for Moderna stock begin trading, offering attractive alternatives for investors.
Fri, 01:34 AM
-Citigroup lowers Moderna's price target from $30 to $28, maintaining a Neutral rating.
Today's Timeline - 23 October
Fri, 06:45 AM
-Moderna halts mRNA-1647 CMV vaccine development after Phase 3 trial fails to meet efficacy targets.
Insights on Moderna, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 107.0M → 142.0M (in $), with an average increase of 24.7% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -1.12B → -825.0M (in $), with an average increase of 16.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 216.3%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.8% return, outperforming this stock by 118.2%
NEGATIVE IMPACTPrice Dip
In the last 3 years, MRNA stock has moved down by -82.3%
About Moderna, Inc.
| Organisation | Moderna, Inc. |
| Headquarters | 325 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Stéphane Bancel |
| E-voting on shares | Click here to vote |
Key Management of Moderna, Inc.
Name | Title |
|---|---|
Mr. Stéphane Bancel | CEO & Director |
Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer |
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations |
Mr. Dave Johnson | Chief Data & AI Officer |
Dr. Stephen Hoge M.D. | President |
Mr. James M. Mock | Chief Financial Officer |
Ms. Tracey Franklin | Chief People & Digital Technology Officer |
Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D. | Chief Development Officer |
Dr. Charbel Haber M.P.H., Ph.D. | Senior VP & Head of Global Regulatory Science |
FAQs
What is Moderna, Inc. share price today?
Moderna, Inc. share price today is $25.36 as on at the close of the market. Moderna, Inc. share today touched a day high of $26.9 and a low of $25.2.
What is the 52 week high and 52 week low for Moderna, Inc. share?
Moderna, Inc. share touched a 52 week high of $57.69 on and a 52 week low of $23.15 on . Moderna, Inc. stock price today i.e. is closed at $25.36,which is 56.04% down from its 52 week high and 9.55% up from its 52 week low.
What is Moderna, Inc.'s market capitalisation today?
Moderna, Inc. market capitalisation is $0.01T as on .
How to invest in Moderna, Inc. Stock (MRNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Moderna, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moderna, Inc. Shares that will get you 0.0591 shares as per Moderna, Inc. share price of $25.36 per share as on October 29, 2025 at 1:29 am IST.
What is the minimum amount required to buy Moderna, Inc. Stock (MRNA) from India?
Indian investors can start investing in Moderna, Inc. (MRNA) shares with as little as ₹88.237 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Moderna, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moderna, Inc. share’s latest price of $25.36 as on October 29, 2025 at 1:29 am IST, you will get 0.3943 shares of Moderna, Inc.. Learn more about
fractional shares .
What are the returns that Moderna, Inc. has given to Indian investors in the last 5 years?
Moderna, Inc. stock has given -59.45% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?